Back | Next |
home / stock / stsa / stsa message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $STSA News Article - Cyrano Therapeutics Announces the Appointment of John Kollins to i | whytestocks | investorshangout | 11/09/2021 8:50:48 PM |
NEWS Satsuma Pharmaceuticals, Inc. Announces Proposed Initial Public O | XenaLives | investorshub | 10/09/2020 1:26:46 PM |
Same 3.95 | Mr Rollup | investorshub | 10/07/2020 5:48:48 PM |
Got in at 3.9 for long hold | Gcasa | investorshub | 10/01/2020 6:35:27 PM |
Thanks. No it was good to call that | muneeflo | investorshub | 09/16/2020 3:10:59 PM |
Certainly wasn't intending to imply a purposeful act | Squirrely_McShitty | investorshub | 09/16/2020 2:30:07 PM |
Yes. It is. I stand corrected, but it | muneeflo | investorshub | 09/13/2020 11:00:10 PM |
What about $10? That would be nice. | muneeflo | investorshub | 09/13/2020 10:41:21 PM |
It will take a PR from the company | Lonewolf1 | investorshub | 09/12/2020 11:52:13 AM |
Earnings per share is -.65, not .65. | Squirrely_McShitty | investorshub | 09/11/2020 6:35:17 PM |
Thanks, and good luck to you as well. | muneeflo | investorshub | 09/11/2020 1:50:14 PM |
For Satsuma Pharmaceuticals Inc (NASDAQ:$STSA), Mizuho downgraded the | muneeflo | investorshub | 09/11/2020 1:48:35 PM |
Nice play. I couldn't pass it up when | bcnuby1 | investorshub | 09/11/2020 12:54:13 PM |
* * $STSA Video Chart 09-10-2020 * * | ClayTrader | investorshub | 09/10/2020 9:51:37 PM |
Just saw your post. I bought at 5.98 | muneeflo | investorshub | 09/10/2020 8:59:51 PM |
I want more $5 shares if the chance | RJ Trotts | investorshub | 09/10/2020 7:34:35 PM |
I jumped out at 8. But I'll be | bcnuby1 | investorshub | 09/10/2020 7:32:52 PM |
I like the bounce that is coming! | RJ Trotts | investorshub | 09/10/2020 7:27:38 PM |
Beautiful bounce. Bouncing all the way to 10+ | bcnuby1 | investorshub | 09/10/2020 4:24:28 PM |
Banking here on the bounce today. eom. | muneeflo | investorshub | 09/10/2020 3:30:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Satsuma Pharmaceuticals Inc. Company Name:
STSA Stock Symbol:
NYSE Market:
DURHAM, N.C., June 15, 2023 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. , a late-stage biopharmaceutical company currently seeking regulatory approval from the U.S. Food and Drug Administration for STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic produc...
January 2024 PDUFA date expected If approved, STS101 would become the only DHE product evaluated in a randomized, placebo-controlled trial (the SUMMIT trial) against modern outcome measures recommended by both the U.S. Food and Drug Administration (FDA) and International Headache Society ...
NEW YORK, NY / ACCESSWIRE / May 1, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hoth Therapeutics, Inc. (NASDAQ:HOTH)'s...